2019
DOI: 10.1016/j.jhazmat.2018.11.038
|View full text |Cite
|
Sign up to set email alerts
|

Thorium decorporation efficacy of rationally-selected biocompatible compounds with relevance to human application

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
9
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 17 publications
(9 citation statements)
references
References 39 publications
0
9
0
Order By: Relevance
“…We have reported synergic radioprotective effects of silibinin with pterostilbene, resulting in 100% of the mice surviving, 30 days after TBI g-irradiation of 7.6 Gy (LD50/30) [ 141 ]. Silibinin can chelate thorium radionuclides ( 232 Th) preventing hemolysis and enhancing liver cells decorporation, which is important because those cells are the major targets of internalized 232 Th [ 143 ].…”
Section: Medical Countermeasuresmentioning
confidence: 99%
“…We have reported synergic radioprotective effects of silibinin with pterostilbene, resulting in 100% of the mice surviving, 30 days after TBI g-irradiation of 7.6 Gy (LD50/30) [ 141 ]. Silibinin can chelate thorium radionuclides ( 232 Th) preventing hemolysis and enhancing liver cells decorporation, which is important because those cells are the major targets of internalized 232 Th [ 143 ].…”
Section: Medical Countermeasuresmentioning
confidence: 99%
“…These drugs act as chelating agents to trap internalized radionuclides and expedite their excretion via urine and feces. However, there remains a scarcity of decorporation agents, particularly for actinides . For instance, diethylenetriamine pentaacetic acid (DTPA) is the only Food and Drug Administration (FDA) approved drug for decorporation of plutonium (Pu).…”
Section: Introductionmentioning
confidence: 99%
“…The main classes of these agents are (1) polyaminopolycarboxylics [diethylenetriaminepentaacetic acid (DTPA)], (2) siderophores (catechol and pyridinone), and (3) macrocycles (calixarenes and crown ethers). Calixarene and crown ether families are potential ligands for actinides; however, these ligands were found to be significantly toxic. , Among all of these decorporating agents, DTPA has been shown to be most effective for actinide decorporation and is the only approved antidote by U.S. Food and Drug administration (FDA) for Pu, curium, and americium decorporation. , Although it forms stable complexes with actinides, DTPA has several limitations such as poor oral bioavailability (∼3%), the requirement of intravenous administration, less retention time in blood plasma, and an inability to reach to actinide-depository organs, etc. , Moreover, the long-term uses of DTPA antidote causes calcium (Ca) and magnesium deficiency, which leads to neurotoxicity, nephrotoxicity, hematopoiesis suppression, etc . Recently, there has been an attempt to explore derivatives of DTPA such as polyethylenimine for Th decorporation; however, the studies are limited to Th complexation without any in vitro/in vivo biological studies .…”
Section: Introductionmentioning
confidence: 99%